GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Stenocare AS (OCSE:STENO) » Definitions » EV-to-FCF

Stenocare AS (OCSE:STENO) EV-to-FCF : -3.83 (As of Dec. 15, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Stenocare AS EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Stenocare AS's Enterprise Value is kr36.66 Mil. Stenocare AS's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 was kr-9.58 Mil. Therefore, Stenocare AS's EV-to-FCF for today is -3.83.

The historical rank and industry rank for Stenocare AS's EV-to-FCF or its related term are showing as below:

OCSE:STENO' s EV-to-FCF Range Over the Past 10 Years
Min: -14.71   Med: -6.22   Max: -2.83
Current: -3.51

During the past 6 years, the highest EV-to-FCF of Stenocare AS was -2.83. The lowest was -14.71. And the median was -6.22.

OCSE:STENO's EV-to-FCF is ranked worse than
100% of 550 companies
in the Drug Manufacturers industry
Industry Median: 25.795 vs OCSE:STENO: -3.51

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2024-12-15), Stenocare AS's stock price is kr1.65. Stenocare AS's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was kr-0.864. Therefore, Stenocare AS's PE Ratio (TTM) for today is At Loss.


Stenocare AS EV-to-FCF Historical Data

The historical data trend for Stenocare AS's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stenocare AS EV-to-FCF Chart

Stenocare AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial - -6.50 -6.47 -6.98 -4.53

Stenocare AS Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.54 -4.53 -11.64 -9.48 -4.85

Competitive Comparison of Stenocare AS's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Stenocare AS's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stenocare AS's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Stenocare AS's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Stenocare AS's EV-to-FCF falls into.



Stenocare AS EV-to-FCF Calculation

Stenocare AS's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=36.662/-9.578
=-3.83

Stenocare AS's current Enterprise Value is kr36.66 Mil.
Stenocare AS's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-9.58 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Stenocare AS  (OCSE:STENO) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Stenocare AS's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=1.65/-0.864
=At Loss

Stenocare AS's share price for today is kr1.65.
Stenocare AS's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-0.864.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Stenocare AS EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Stenocare AS's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Stenocare AS Business Description

Traded in Other Exchanges
Address
Nyholmsvej 4, Randers NØ, DNK, 8930
Stenocare AS is a Danish company engaged in the cultivation and production of medical cannabis products through pharmacies and hospitals. The Company's business operations include the distribution and sales of imported products to several markets which also includes local cultivation and production of its medical cannabis products. Stenocare is well positioned to become a market leader in Denmark and a vendor in Europe. The Company is a supplier of medical cannabis oil for patients in Denmerk, Sweden, UK, Australia and Norway. It has an indoor production facility for the cultivation and production of medical cannabis at Randers, Denmark.

Stenocare AS Headlines

No Headlines